A study of more than 1000 elderly patients has revealed that there are no links between statin medication and cognitive decline.
Browsing: Cognitive/neurodegenerative disorders
What are the challenges associated with identifying risk genes for Alzheimer’s disease? What more needs to be done to successfully translate this genetic data into potential therapeutics? Watch our video with Owen Peters to find out more.
A research team have discovered a new mechanism by which elovanoids may protect retinal and brain cells against neurodegenerative diseases such as Alzheimer’s and age-related macular degeneration.
What might the mechanisms behind circadian dysfunction in the early stages of dementia be? What more needs to be done to successfully translate this into the clinic? Watch our video with Marco Brancaccio to find out.
At the UK–Korea Neuroscience Symposium (12–13 August, London, UK), we had the fantastic opportunity of interviewing Justin Lee (Institute for…
Chinese pharmaceutical firm, Shanghai Green Valley Pharmaceuticals, has gained conditional approval from the country’s regulatory agency for oligomannate as a treatment for mild-to-moderate Alzheimer’s disease.
A woman genetically predisposed to have early-onset autosomal dominant Alzheimer’s disease at the age of 40 did not display symptoms until her 70s. This has been linked to the presence of a rare gene variant termed APOE3ch.
In this video, we spoke with Kei Cho (UK DRI, King’s College London, UK) to find out more about the UK–Korea Neuroscience Symposium and how this collaboration has developed over the last few years.
Four studies presented at SfN Neuroscience have demonstrated how the microbiome interacts with the brain in mice, revealing the possible mechanisms behind gut–brain communication.